Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117235) titled 'The Efficacy and Safety of Anaprazole Quadruple Therapy Versus Rabeprazole Quadruple Therapy for Helicobacter pylori Eradication: A Prospective, Multicenter, Open-label, Randomized Controlled Clinical Study' on Jan. 21.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: NanJing First Hospital
Condition:
Helicobacter pylori gastritis
Intervention:
Group A:Anaprazole + Amoxicillin + Furazolidone + Colloidal Bismuth Pectin
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-01-27
Target Sample Size: Group A:110;Group B:110;
Countries of Recruitment:
China...